Literature DB >> 8774136

Hepatocyte proliferation induced by a single dose of a peroxisome proliferator.

T Ohmura1, G M Ledda-Columbano, R Piga, A Columbano, J Glemba, S L Katyal, J Locker, H Shinozuka.   

Abstract

In compensatory hyperplasia after partial hepatectomy or liver cell injury, hepatocyte proliferation is triggered by coordinated actions of growth factor such as hepatocyte growth factor and transforming growth factor-alpha and -beta. Initiation of hepatocyte DNA synthesis is preceded by the activation of the set of early growth response genes mediated by enhanced nuclear factor-kappa B binding to DNA. Using an experimental model to induce hepatocyte DNA synthesis in vivo by a single dose of a peroxisome proliferator, which does not induce liver cell necrosis (direct hyperplasia), we investigated whether peroxisome proliferator-induced hepatocyte proliferation involved an induction of known growth factors, an activation of early growth response genes, and nuclear factor-kappa B. A single intragastric administration of 250 mg/kg BR931 (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl) acetamide) to male wistar rats induced a wave of hepatocyte DNA synthesis starting after 12 hours and peaking at approximately 24 to 36 hours. The response was dose dependent. The treatment also induced the expression of the mRNA for the peroxisomal bifunctional enzyme, one of the peroxisome-related fatty acid beta-oxidation enzymes. Pretreatment of rats with dexamethasone (2 mg/kg) inhibited both hepatocyte DNA synthesis and the induction of the peroxisomal bifunctional enzyme gene. Northern blot analyses of liver RNA during a period preceding the onset of DNA synthesis revealed no induction of hepatocyte growth factor, transforming growth factor-alpha, or tumor necrosis factor-alpha mRNAs. No induction of early growth response genes, liver regeneration factor-1, or c-myc was detected. Furthermore, gel mobility shift assays showed no enhanced nuclear factor-kappa B binding to its DNA consensus sequence after BR931 treatment, whereas control studies demonstrated a distinct increase in binding after partial hepatectomy or lead nitrate treatment. The results suggest that peroxisome-proliferator-induced hepatocyte proliferation may be triggered by signal transduction pathways different from those after partial hepatectomy and that the binding of peroxisome proliferators to their nuclear receptors may play a role in stimulation of DNA synthesis and peroxisome proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774136      PMCID: PMC1861716     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Receptor-mediated mechanisms of peroxisome proliferators.

Authors:  S Green
Journal:  Biochem Pharmacol       Date:  1992-02-04       Impact factor: 5.858

2.  The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes.

Authors:  K L Mohn; T M Laz; J C Hsu; A E Melby; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.

Authors:  M Tewari; P Dobrzanski; K L Mohn; D E Cressman; J C Hsu; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

4.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

5.  Expression of myc, fos and Ha-ras associated with chemically induced cell proliferation in the rat liver.

Authors:  T L Goldsworthy; S M Goldsworthy; C S Sprankle; B E Butterworth
Journal:  Cell Prolif       Date:  1994-05       Impact factor: 6.831

6.  Differential expression of hepatocyte growth factor, transforming growth factor-alpha and transforming growth factor-beta 1 messenger RNAs in two experimental models of liver cell proliferation.

Authors:  M Masuhara; S L Katyal; T Nakamura; H Shinozuka
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

7.  The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat.

Authors:  F Beck; S Plummer; P V Senior; S Byrne; S Green; W J Brammar
Journal:  Proc Biol Sci       Date:  1992-02-22       Impact factor: 5.349

8.  Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4.

Authors:  J M Tian; U Schibler
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

Review 9.  Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration.

Authors:  K Matsumoto; T Nakamura
Journal:  J Gastroenterol Hepatol       Date:  1991 Sep-Oct       Impact factor: 4.029

10.  The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene.

Authors:  J D Tugwood; I Issemann; R G Anderson; K R Bundell; W L McPheat; S Green
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  8 in total

Review 1.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.

Authors:  G M Ledda-Columbano; M Pibiri; R Loi; A Perra; H Shinozuka; A Columbano
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  Liver repopulation for the treatment of metabolic diseases.

Authors:  M Grompe
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

4.  Gadd45 in the Liver: Signal Transduction and Transcriptional Mechanisms.

Authors:  Jianmin Tian; Joseph Locker
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

6.  Caspase 2 activation and ER stress drive rapid Jurkat cell apoptosis by clofibrate.

Authors:  Fabio Penna; Fabrizio Pin; Domiziana Costamagna; Patrizia Reffo; Francesco Maria Baccino; Gabriella Bonelli; Paola Costelli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  During thioacetamide-induced acute liver failure, the proliferative response of hepatocytes to thyroid hormone is maintained, indicating a potential therapeutic approach to toxin-induced liver disease.

Authors:  Raza Malik; Rebecca Saich; Tony Rahman; Humphrey Hodgson
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

8.  The Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.

Authors:  Howard P Glauert; Karen Calfee-Mason; Yixin Li; Vani Nilakantan; Michelle L Twaroski; Job Tharappel; Brett T Spear
Journal:  PPAR Res       Date:  2009-01-29       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.